MHRA

#AstraZeneca #Covid-19 #Marketing approval authorisation #MHRA

Covid-19 approval milestone for those who can’t be vaccinated 

AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab) has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) and is the first antibody combination for pre-exposure prophylaxis (PrEP) against Covid-19 licensed in Great Britain.   The use of this medicine is for adults who are not currently… Read More

#News #Trending News